Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ready to rumble!!!!!by the way where are the clowns today hahaha..
Idea opinion on how the company pay for the upcoming (2) Phase 2 trialS? TIA
INIT- Thanks I will check.
Jcbaby- do you have or anyone know A link that insider is buying.. TIA
For the same reason why went down!
Dane, I will go for - he’s about to deliver.
---------------
in response to:
"It’s pretty obvious that either Leo is insane and/or delirious with visions of grandeur (Walter Mitty!) or he’s about to deliver. "
IMO, B-0M licensing deal as to when I don't know but very soon.
Hey Doc not bc in the ER?
The Co. Searching for Future HQ...Very Interesting!!!
"In early 2018, the Company approved steps to focus its efforts on clinical trials for its lead drug candidates. The Company’s office and laboratory needs have
shifted from compound discovery to clinical development programs. The Company is now in the process of searching sites for its future headquarters."
Boo- I think several months ago one of the respected medical poster here who I follow said that he is expecting another bump before take off, I think this is it..
and I just added 60k.
and currently researching what "business development negotiations" means-
GL to us.
Looking for one day we are up $20..
https://ih.advfn.com/p.php?pid=nmona&article=77395919
P-mfg method pending
Brilacidin Mfg method - In-process
Prurisol Mfg method - Prov. pending
Here- Will do.
Barron Thanks! Sound reasoning post but hopefully no R/S - I also believe " deal is being negotiated and nearing completion."
Daub -Agreed ! very rewarding LICENSING deal.IMO, GL to us
I am sure there is no shares for you to sell!!!
While you guys do what you do best, I just added 15k @.38 !!
GL fellow long, I have 2-5 years on this from now.
kfc, Thank you for sharing !!! have a nice day.
Nice! Lets close green and hopefully its starts of the trend. GL all fellow LONGS.
Lilk - Thanks for the post, also found this link regarding interim analysis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703711/
" aspire will sell into any rally, this sucks " - And so as the flippers and traders- Good thing I am a Investor.
"Maybe this explains last week’s Aspire (and other) selling. " I disagree.
And? please care to post your analysis. and see what you got!!!
Be careful you might need IPIX drugs one day.
Barrowed from BioH post, hope its ok to repost..
"When a deal comes through, imagine the response of the market when the balance sheet is improved by 10-100M (based on the compound, indication, and market/exclusively) and IPIX now has the ability to run additional trials for purisol, brilaciden and kevetrin. Analysis and other BP will take note and the days of fighting the FUD on the OTC BB will be over. There will be other challenges but they will be at a much larger scale."
Top123
Plenty - Thanks from your perspective of P2b trial results.
Hopefully on or before end of this month.
Got it Thanks MM-
MM please clear my bid @.49/15k, good news keep coming!!
SOON and very SOON, Good things come to those who wait.
BioD, BioH, SOX, Plenty and others thank to all the very informative post.
Welcome back Cabel- Hope you enjoying your golf and prep for retirement.
GL to all fellow longs.
Everybody entitle to their own opinions on what is the valuation of the company whether its 100M, 1B, 10B or even 100B it doesn't not change a thing.
Relax take you meds.
Good post and I agree, very reasonable projections.
LOL- Leo and team will not base their decision on your or anybody's timeline here.
OOppps !!Protagonist cans ulcerative colitis trial after flunking interim review
B-UC (UP/UPS) is available if not taken already..
https://www.fiercebiotech.com/biotech/protagonist-cans-ulcerative-colitis-trial-after-flunking-interim-review
Farrell - Reg K, very interesting old article/interview of Dr M. just fyi-
" I even asked Dr. Menon if he was this excited with Gemzar and Alimta and he assured me that he was not and that Kevetrin™ could be much, much
bigger (he had to reiterate “could” as a matter of course of conduct). From a different perspective, each conversation with the Cellceutix staff was a real pleasure because of the honest-to-goodness excitement in the air.
They never seem to leave the lab. They’re there 12 to 14 hours a day, 7
days a week grinding away at more at more tests almost just so they can
say “Yup, Kevetrin™ worked on that too!”
What cancer will be tested next has not been released by Cellceutix, nor
would they speak to me about it for disclosure reasons, but there was
some “dancing around the bush” that it could be huge news if the ongoing
research is successful. I wish that I could offer more information as they have already hit the “big dogs” of cancers: breast, lung, colon and
leukemia. Pancreatic cancer, if not caught early, is a death sentence, so perhaps that is on the agenda, but that is purely a speculative guess on my part. Clinical Trials for Kevetrin™ Cellceutix is nearing the targeted date of filing their Investigational New Drug (IND) application with the U.S. Food and Drug Administration and reported that it should be submitted in May 2011. Barring any complications, Kevetrin™ should be in humans as a cancer treatment sometime around August 2011. Confidentiality has kept the hospital location from being released, but it has been stated that the trials will be held at one of the world’s most prominent cancer centers.
Put your thinking cap on and pay attention as here is the most important
thing to understand about Phase I clinical trials for Cellceutix. Typically, Phase I trials address safety for a new drug. For obvious reasons, the FDA,the hospital and the biotech firm have to make sure that giving their new drug to a human isn’t going to kill them and they have to evaluate tolerable dosage levels.
This process will not be true in the same manner for Cellceutix. Their
patients will consist of the worst of the worst cancer patients; patients that have late stage or terminal cancer. This is EXACTLY what a Company like Cellceutix wants to see. Remember, they are targeting extreme, drugresistant cancers with Kevetrin™.
There will obviously be an evaluation of safety component to the trials, but efficacy, although not the intent of the study, will be noted. If Kevetrin™ demonstrates efficacy on any level, it’s not a window of opportunity opening for Cellceutix, it’s a set of barn doors flying open as they will have a drug that can be of benefit to a terminal patient. It will need to be moved as quickly as possible to be tested as a front-line defense.
While most people believe that the FDA review process is extremely slow
and that it takes nine to eleven years to bring a drug to market, this is not true on every occasion. The FDA has programs in place to expedite new drugs to advanced clinical stages that meet an area of great unmet medical need. The “Accelerated Approval” and “Priority Review” programs are exactly what Cellceutix will be focused upon should efficacy should be demonstrated which could literally mean a jump straight to Phase III
clinical trials after a very minimal time in Phase I. Per standard protocol,when Phase III is completed, a New Drug Application (NDA) is filed, which also can be moved through at an expeditious pace. Abbot Laboratories, Inc. is a prime example as their HIV infection drug, Norvir, received NDA approved in 72 days from the date of submittal.
Why is Kevetrin™ a strong candidate for this sort of fast-tracking? Because Kevetrin™ is like nothing else. It is, in fact, classified as a completely new chemical entity in medicine. Read that again. It’s a “completely new chemical entity in medicine.” That’s how unique it is. It also is being developed to treat diseases that kill over 100,000 people annually. If Kevetrin™ proves safe in humans and eliminates cancer as is has in animal studies, it should move rapidly through the FDA approval process. What normally would take years and years of clinical trials could be slashed to as little as 24 or 30 months for Kevetrin"
lol. Sixmill- you are really slick and sophisticated wall street veteran as you said, you know very well NO BK, NO R/S. well at least you have manners when you are posting even if it's FUD.
Have a good day.
Wow frrol 600k shares, I am only half of that..
frrol -Good post!
jhaw- That's true, Aspire in the last filling sold little compare to the previous fillings, now that we don't have trials, huge payroll cut- there will be very minimum aspire selling if needed..
For the meantime LEO and team working on partnership options.
It reminds me of the movie Ocean's Eleven, "you never beat the house until you have the perfect hand and then put everything on the table"
And so I am ALL in.
GL to ALL fellow longs.
Farrell and frrol - Thanks to both of you and have a wonderful weekend. signing off weekend family time start now..
frrol - sound like you are well verse on licensed compound, Is PolyCide part of IPIX deal? do ipix have it?
TIA
quote from old article but still -
"The pharmaceutical industry “continues to be willing to pay whatever price it has to in order to secure the asset it feels it just has to have,” Simos Simeonidis, a biotech analyst at RBC Capital Markets, wrote in a note to investors "
Boo- Even hurricane hit this stock I WILL NOT SELL!!! I have done buying reach my limit shares all I ask is $4.00/share to hit my $M..ALL IN.. even if this goes to zero it sure put a little ding into my savings but not enough to put a dent.
I maybe amateur investor compare to most here but I know how to play cards with that said IMO we have a ROYAL FLUSH here, we have already KING, QUEEN, JACK and 10 of red diamond and waiting for the !!!
Leo when you and partners are ready show us that ACE diamond..
GL to ALL..